Yttrium-90 (^<90>Y) ibritumomab tiuxetan (Zevalin) induces long-term durable responses in patients with relapsed or refractory B-cell non-Hodgkin's lymphoma

Author(s)

Journal

  • Cancer Biother Radiopharm

    Cancer Biother Radiopharm 20, 185-188, 2005

Cited by:  1

Codes

  • NII Article ID (NAID)
    10024002990
  • Article Type
    Journal Article
  • Data Source
    CJPref 
Page Top